| |
NAL Captive DDS Technologies |
|
Bio-D3 Transdermal DDS Technology
|
| Bio-D3 Transdermal DDS |
Injectable / Oral Drugs
|
|
Transdermal Delivery |
ODT, Capsule, or Tablet
Absorption via GI Tract |
|
Patch, Cream, or Gel
Absorption via Skin |
|
Disadvantages
|
|
Advantages |
· Short Duration
· Low Bioavailability
· Frequent Dosing
· High Peak-And-Valley
Plasma Levels |
· Up to 7 Day Duration
· Improved Bioavailability
· Less Frequent Dosing
· More Constant Plasma
Levels |
|
|
|
|
|
